“Green light” for emergency use lit today, Wednesday o World Health Organisation (WHERE) for coronavirus vaccine of the Indian pharmaceutical industry Bharat Biotech, paving the way for the locally produced vaccine to be accepted as a valid vaccine in many poor countries.
“The Technical Advisory Group decided that Covaxin vaccine “It meets the WHO criteria for protection against COVID-19, that the benefit of the vaccine far outweighs the risks, and that the vaccine can be used,” the international body said in a tweet.
The WHO advisory committee was expected to decide on the vaccine known as Covaxin last week, but asked Bharat Biotech for further clarification before conducting a final risk-benefit assessment of global vaccine use, according to the APE. .
Covaxin Vaccine: How to give the medicine
Covaxin was also reviewed by the WHO Strategic Advisory Group on Immunization, which recommended its use in two doses, with one four weeks between doses, for all age groups from 18 years and over.
The emergency license will allow Bharat to ship the vaccine to countries that depend on WHO guidance for the decisions of their regulators.
Covaxin is the seventh vaccine approved by the WHO after the two mRNA vaccines of Pfizer / BioNTech and Moderna, the adenovirus vector vaccines made by AstraZeneca and Johnson & Johnson and the Chinese inactivated virus vaccines from Sinovac Biotech and Sinopharm.
Approval also means that the vaccine can be accepted as a valid vaccine for millions of Indians who have received it and want to travel abroad.
Oman last week and Australia said Monday they would recognize Covaxin as a valid vaccine for travelers.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
